An interventional study of NRT proposition and exhaled CO measurement in Smoking Cessation, sponsored by Groupe Hospitalier Mutualiste de Grenoble. Terminated at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-16.
Sponsored by Groupe Hospitalier Mutualiste de Grenoble · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Smoking Cessation with a site in France — 8 open to participants now, 11 under way, 1 of them phase 3. Smoking Cessation · France.
Among the 48 studies in Smoking Cessation with a site in France, this one is the 39th largest by enrollment of the 43 interventional ones that give a count, is one of 3 that started in 2020, is one of 21 with no phase, and was the 27th registered.
1,583 studies on the registry are indexed under Smoking Cessation; 196 are open to participants now.
Browse Smoking Cessation studies →8 of the 48 studies in Smoking Cessation with a site in France are open now. Recruiting first, the newest first:
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 50–74
Institut du Cancer de Montpellier - Val d'Aurelle · Sites in France
Ages 18+
Groupe Hospitalier Mutualiste de Grenoble · Sites in France
Ages 18+
Poitiers University Hospital · Sites in France
Ages 18+
Poitiers University Hospital · Sites in France
Ages 18–25
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 134 Smoking Cessation studies recruiting now, 92 (69%) set no upper age limit and 35 (26%) stop at 75 or younger; 6 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 3 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 163 across 1,425 interventional studies indexed under Smoking Cessation.
Median enrollment 124 across the 43 interventional studies, 112 across the 5 observational. Of the 34 that completed or were terminated, 6 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
16 of 48 have an industry lead sponsor. The 10 most frequent:
Groupe Hospitalier Mutualiste de Grenoble is the lead sponsor of 12 studies on the registry; 4 are open to participants now.
Groupe Hospitalier Mutualiste de Grenoble has 2 studies filed under Smoking Cessation — fewer than ten, so there is no comparison to draw.
3 of the studies in Smoking Cessation with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06910566Centre Oscar LambretFactors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy | 2026-11 |
| NCT06988644Groupe Hospitalier Mutualiste de GrenobleImpact of a Counseling Consultation in the Workplace for Smoker Health Professionals | 2026-11-30 |
| NCT07198971Institut du Cancer de Montpellier - Val d'AurelleFeasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for Cancer | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 48 studies in Smoking Cessation with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Smoking is associated with a higher rate of surgical complications. For example, in orthopedics, the risk of complications is 31% in smokers against 5% in non-smokers. The management of this addiction is recommended and particularly interesting in scheduled surgery, because it allows smoking cessation well before the procedure. However, for patients who cannot consider this smoking cessation, the mere information of the risk cannot be sufficient and a real strategy must be constructed and evaluated.
Currently, studies results indicate that a patient reducing the number of smoked cigarettes will unconsciously modify their smoking behaviour to obtain the usual nicotine level, this effect is called self-titration. Conversely, nicotine replacement while continuing consumption could induce an improvement in smoking behaviour, therefore less intoxication which would be beneficial in terms of reduction of post-operative complications. This study seeks to assess the effectiveness of a systematic proposition of nicotine replacement therapy (NRT) in regular smokers. Tobacco addiction specialists have demonstrated that intoxication and dependence are well correlated with the exhaled carbon monoxide (CO) level, so this measurement will be used in addition to the patient's interview.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: NRT proposition and exhaled CO measurement
Nicotine replacement therapy is proposed to every patient included in the study. Whether the patient accepts the therapy or not, exhaled carbon monoxide is measured at the preoperative consultation (about 15 days before surgery) and the day of surgery by a nurse. These two measures are compared to assess efficacy of nicotine replacement therapy.
Efficacy of a systematic proposition of nicotine replacement therapy, regardless of the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitor
Time frame: At inclusion, and before surgery
Number of patients who refuse nicotine replacement therapy
Time frame: At inclusion
Effect of nicotine replacement therapy on the type of analgesics administrated
Time frame: At inclusion, before surgery, and 2 days after surgery
Effect of nicotine replacement therapy on the duration of analgesics administrated
Time frame: At inclusion, before surgery, and 2 days after surgery
Effect of nicotine replacement therapy on the dose of analgesics administrated
Time frame: At inclusion, before surgery, and 2 days after surgery
Number of smoking cessations
Time frame: 2 days after surgery
Efficacy of a systematic proposition of nicotine replacement therapy, depending on the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitor
Subgroup analysis of the primary endpoint according to predefined groups
Time frame: At inclusion, and before surgery
Ran from Aug 2020 to primary completion in May 2022, 21 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Groupe Hospitalier Mutualiste de Grenoble